{"filing":{"accession_number":"0001628280-26-063369","cik":"0001854270","ticker":"SNTI","company_name":"Senti Biosciences Holdings, Inc.","form":"8-K","filing_date":"2026-09-24","report_date":"2026-09-23","primary_document":"snti-20260923.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1854270/000162828026063369/snti-20260923.htm"},"events":[{"id":34862,"run_id":32100,"accession_number":"0001628280-26-063369","anchor_item_number":"5.02","event_type":"exec_departure","event_domain":"governance","is_material":true,"confidence":0.95,"summary":"Dr. Brenda Cooperstone resigned from the Board of Directors and her position as Chair of the Compensation Committee, effective immediately on September 23, 2026. The disclosure centers on a director's departure rather than an appointment or compensation arrangement. Board departures, particularly of committee chairs, are material to investors as they affect governance and oversight structure.","company_name":"Senti Biosciences Holdings, Inc.","ticker":"SNTI","filing_date":"2026-09-24","form":"8-K","submitted_at":null,"items":[{"id":38716,"accession_number":"0001628280-26-063369","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.","event_type":"exec_departure","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"Dr. Brenda Cooperstone resigned from the Board of Directors and her position as Chair of the Compensation Committee, effective immediately on September 23, 2026. The disclosure centers on a director's departure rather than an appointment or compensation arrangement. Board departures, particularly of committee chairs, are material to investors as they affect governance and oversight structure.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-24T20:05:57.108017+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":38716,"accession_number":"0001628280-26-063369","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.","event_type":"exec_departure","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"Dr. Brenda Cooperstone resigned from the Board of Directors and her position as Chair of the Compensation Committee, effective immediately on September 23, 2026. The disclosure centers on a director's departure rather than an appointment or compensation arrangement. Board departures, particularly of committee chairs, are material to investors as they affect governance and oversight structure.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-24T20:05:57.108017+00:00","company_name":"Senti Biosciences Holdings, Inc.","ticker":"SNTI","filing_date":"2026-09-24"}]}